These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1503448)

  • 1. In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods.
    Aldridge KE; Schiro DD; Varner LM
    Antimicrob Agents Chemother; 1992 Apr; 36(4):854-5. PubMed ID: 1503448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci.
    von Eiff C; Peters G
    Zentralbl Bakteriol; 1996 Apr; 283(4):497-501. PubMed ID: 8737948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
    Pechère JC
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci.
    Archer GL; Auger P; Doern GV; Ferraro MJ; Fuchs PC; Jorgensen JH; Low DE; Murray PR; Reller LB; Stratton CW
    Diagn Microbiol Infect Dis; 1993; 16(3):223-6. PubMed ID: 8477576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-antibiotic effect of the new streptogramin RP 59500.
    Chin NX; Neu HC
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):642-5. PubMed ID: 1396777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies.
    Hoban DJ; Weshnoweski B; Palatnick L; Zhanel CG; Davidson RJ
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():59-65. PubMed ID: 1399952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin.
    von Eiff C; Reinert RR; Kresken M; Brauers J; Hafner D; Peters G
    J Clin Microbiol; 2000 Aug; 38(8):2819-23. PubMed ID: 10921933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
    Brumfitt W; Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France.
    Soussy CJ; Acar JF; Cluzel R; Courvalin P; Duval J; Fleurette J; Megraud F; Meyran M; Thabaut A
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():53-8. PubMed ID: 1399951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Leclercq R; Nantas L; Soussy CJ; Duval J
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():67-75. PubMed ID: 1399953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro study of strains of Staphylococcus: choice of an antibiotic].
    Messmer JC; Lecaillon-Thibon E; Soler H
    Sem Hop; 1984 May; 60(19):1329-32. PubMed ID: 6326323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci.
    Fass RJ
    Antimicrob Agents Chemother; 1991 Mar; 35(3):553-9. PubMed ID: 1903912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem?
    Sanchez ML; Flint KK; Jones RN
    Diagn Microbiol Infect Dis; 1993; 16(3):205-13. PubMed ID: 8477574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
    von Eiff C; Peters G
    J Antimicrob Chemother; 1999 Apr; 43(4):569-73. PubMed ID: 10350389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae.
    Fremaux A; Sissia G; Cohen R; Geslin P
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():19-23. PubMed ID: 1399946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.
    Auckenthaler R; Courvalin P; Féger C; Roche G;
    Clin Microbiol Infect; 2000 Nov; 6(11):608-12. PubMed ID: 11168064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
    Jones RN; Barry AL; Gardiner RV; Packer RR
    Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.
    Schwalbe RS; McIntosh AC; Qaiyumi S; Johnson JA; Johnson RJ; Furness KM; Holloway WJ; Steele-Moore L
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2416-9. PubMed ID: 8891155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Teicoplanin and vancomycin susceptibility in Staphylococcus aureus and coagulase-negative staphylococci].
    Caiaffa Filho HH; Lima Mde P; Sinto SI; Andriolo A; Mendes CM
    Rev Assoc Med Bras (1992); 1994; 40(2):77-80. PubMed ID: 7820154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
    Fantin B; Leclercq R; Merlé Y; Saint-Julien L; Veyrat C; Duval J; Carbon C
    Antimicrob Agents Chemother; 1995 Feb; 39(2):400-5. PubMed ID: 7726505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.